# The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

> **NCT01927406** · PHASE4 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Thyroid Eye Disease
- Ocular Hypertension
- Glaucoma

## Interventions

- **DRUG:** Prostaglandin Analog
- **DRUG:** Timolol

## Key facts

- **NCT ID:** NCT01927406
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding source unavailable
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01927406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01927406, "The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01927406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*